Abstract: The present invention provides derivatives of Escherichia coli constructed for the production of lactic acid. The transformed E. coli of the invention are prepared by deleting the genes that encode competing pathways followed by a growth-based selection for mutants with improved performance. These transformed E. coli are useful for providing an increased supply of lactic acid for use in food and industrial applications.
Type:
Grant
Filed:
December 7, 2009
Date of Patent:
April 23, 2013
Assignee:
University of Florida Research Foundation, Inc.
Inventors:
Shengde Zhou, Lonnie O'Neal Ingram, Keelnatham T. Shanmugam, Lorraine Yomano, Tammy B. Grabar, Jonathan C. Moore
Abstract: A therapy or prophylaxis of K. pneumoniae infections with a lytic bacteriophage specifically against K. pneumoniae, provides a lytic bacteriophage (DSM 24329) to a K. pneumoniae infected organism for the sake of relieving the serious complications of liver abscesses and bacteremia, and the high mortality rate of K. pneumoniae infections in Taiwan.
Abstract: The present invention relates to implantable medical devices coated with polymer having hemocompatible and/or prohealing moieties appended thereto and to their use in the treatment of vascular diseases.
Abstract: In certain embodiments provided are composition suitable for cleansing or treating the skin, the composition comprising: (i) at least 90% water; (ii) a non-ionic surfactant; (iii) one or more hydrophobic emollients present in a concentration from about 200 parts per million (ppm) to about 4000 ppm, and wherein the composition has a ratio of total surfactant concentration to total hydrophobic emollient concentration that is from about 0.5 to about 2.5. In other embodiments, provided are articles comprising a water-insoluble absorbent substrate and a composition comprising a polyol polyhydroxystearate or a water-soluble glyceryl polyacrylate impregnated therein.
Type:
Grant
Filed:
December 4, 2008
Date of Patent:
May 8, 2012
Assignee:
Johnson & Johnson GmbH
Inventors:
Pietro Rosato, Rainer Lange, Johannes Crotogino
Abstract: The present invention encompasses a coating on the surface of a substrate and the coated substrates. The coating includes a polymer, an olimus drug (sirolimus, everolimus, zotarolimus, etc.), and a dexamethasone derivative. The polymer may be a hydrophobic polymer, preferably a fluoropolymer, and more preferably a fluoropolymer with at least 25% vinylidene fluoride by weight.
Type:
Grant
Filed:
September 29, 2008
Date of Patent:
January 10, 2012
Assignee:
Abbott Cardiovascular Systems Inc.
Inventors:
Stephen D. Pacetti, John L. Toner, Keith R. Cromack
Abstract: A firm but pliable medical device for use as a bone graft substitute or bone graft extender retains its shape without the requirement of a containment device, such as a syringe. Because the device is solid, it is easy to locate or position in-vivo and, in the moist environment of the body, it will hold its shape well, for an extended time. Because the lyophilized pliable medical device is porous, it adsorbs blood and other beneficial cells containing body fluids, such as bone marrow, contributing to its superior bone repair efficacy in comparison to an analogous putty that has not been lyophilized. In addition these lyophilized pliable medical devices are easier to terminally steam sterilize than the analogous putty because there is no moisture present to boil and “blow-out” of the containment device (syringe). The glycerin that is present in the formulation lends pliability but has a low vapor pressure.
Type:
Grant
Filed:
December 16, 2005
Date of Patent:
November 1, 2011
Assignee:
Cerapedics, Inc.
Inventors:
James John Benedict, Greg Allen Brewster, Donald Barclay Freeman